QID 378129

Date Published: 2023-04-04

QID 378129: Red Hat OpenJDK 8u292 Windows Builds release and Security Update (RHSA-2021:1445)

The OpenJDK 8 packages provide the OpenJDK 8 Java Runtime Environment and the OpenJDK 8 Java Software Development Kit.

This release of the Red Hat build of OpenJDK 8 (1.8.0.292) for Windows serves as a replacement for the Red Hat build of OpenJDK 8 (1.8.0.282) and includes security and bug fixes, and enhancements.
OpenJDK: Incorrect handling of partially quoted arguments in ProcessBuilder on Windows (Libraries, 8250568) (CVE-2021-2161)
OpenJDK: Incomplete enforcement of JAR signing disabled algorithms (Libraries, 8249906) (CVE-2021-2163)
Affected Versions:
Red Hat build of OpenJDK 8 (1.8.0.282) and later Versions and Prior to OpenJDK 8 (1.8.0.292)

QID Detection Logic (Authenticated)
This QID checks for the below registry keys HKLM\SOFTWARE\Microsoft\Windows\CurrentVersion\Uninstall" ,"HKLM\SOFTWARE\Wow6432Node\Microsoft\Windows\CurrentVersion\Uninstall and sub values to check Publisher and Display version.

Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Java SE.

  • CVSS V3 rated as Medium - 5.9 severity.
  • CVSS V2 rated as Medium - 4.3 severity.
    • Solution
    For more information regarding the update RHSA-2021:1445
    Vendor References

    CVEs related to QID 378129

    CVE-2021-2161 | CVE-2021-2163 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2021:1445 URL Logo access.redhat.com/errata/RHSA-2021:1445
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].